Evaluate the Safety and Efficacy of Naftifine Hydrochloride Cream 2% and Naftin® Cream 2% in Patients With Tinea PedisA Study Of Diflucan In Children With Ringworm Of The ScalpEfficacy and Safety of LAS41003 in the Treatment of Inflammatory Tinea PedisA Study to Evaluate Efficacy and Safety of Three W0027 Regimens in the Treatment of Moccasin Type Tinea Pedis (MTTP)Multicenter Study of the Efficacy and Safety of Luliconazole Cream in Tinea Pedis (Athlete's Foot)Senna Alata Leaf Decoction as a Treatment for Tinea ImbricataHygienic Socks With Antifungal Agent-loaded Microcapsules for Patients With Tinea PedisA Therapeutic Equivalence Study of Two Oxiconazole Nitrate Topical Cream Treatments for Patients With Tinea PedisSafety of a Topical Antifungal Treatment for Tinea Cruris, Tinea Pedis and Tinea CorporisSafety and Efficacy of Econazole Nitrate Foam 1% and Foam Vehicle in Subjects With Tinea PedisTopical Antifungal Treatment for Tinea CrurisNon-inferiority Trial of Dapaconazole Versus KetoconazoleA Comparison Study of UHE-103 Cream in Subjects With Moccasin Type Tinea PedisStudy With Nåva Foot Cream in Patients With Tinea Pedis InterdigitalisTopical Antifungal Treatment for Tinea PedisEvaluation of the Efficacy and Safety of NAFT-600 in Subjects With Tinea PedisEfficacy and Safety of NAFT-600 in Subjects With Tinea PedisClinical Equivalence of Two Generic Butenafine Hydrochloride 1% Creams as Compared to Lotrimin Ultra Cream in Patients With Interdigital Tinea PedisAn Efficacy Study of a New Formulation of Ketoconazole 2% Cream in Patients With Tinea Pedis, Commonly Known as Athlete's FootEffectiveness Study of Ketoconazole and Betamethasone to Treat Fungal Infection and DermatophytosisStudy Evaluating the Drug Interaction Potential of Luliconazole Cream 1% in Subjects With Tinea Pedis and Tinea CrurisEvaluation of Preclinical Toxicity andTherapeutic Efficacy of Kandhaga Rasayanam in PadarthamaraiPediatric Subjects With Tinea CorporisComparative PK Study of Econazole Nitrate Foam and Econazole Nitrate Cream in Subjects With Interdigital Tinea Pedis Aged 12 Years to Less Than 18 YearsEvaluate the Clinical Equivalence of Two Naftifine HCl 1% Creams in Patients With Interdigital Tinea PedisEvaluate the Safety & Bioequivalence of a Generic Butenafine Cream & Lotrimin Ultra® & Compare Both to a Vehicle Control in Treatment of Interdigital Tinea PedisEfficacy and Safety of Terbinafine Film Forming Solution in Patients With Tinea PedisSafety and Efficacy of Econazole Nitrate Foam 1% in Subjects With Tinea PedisEvaluate the Efficacy and Safety of Tolnaftate Cream in the Treatment of Patients With Fungal InfectionsA Dose Response Trial to Evaluate Clinical and Mycological Effect of Nitric Oxide in Subjects With Tinea PedisSafety and Efficacy of a Novel Topical Therapy for Tinea Pedis (Athlete's Foot)Clinical Equivalence of Two Butenafine Hydrochloride 1% Creams in Patients With Interdigital Tinea PedisSafety and Equivalence of a Generic Ciclopirox Olamine Topical Suspension Compared to the Reference Ciclopirox Topical Suspension 0.77% for the Treatment of Tinea PedisSafety and Equivalence of a Generic Ciclopirox Olamine Cream Compared to the Reference Ciclopirox Cream 0.77% for the Treatment of Tinea PedisEfficacy Study to Evaluate the Effect of Nitric Oxide on the Treatment of Tinea Pedis (Athlete's Foot)A Study of Econazole Foam 1% in Athlete's FootMulticenter Study of the Safety and Efficacy of NAFT-500 in Tinea CrurisMulticenter Study of the Safety and Efficacy of NAFT-500 in Tinea PedisClinical Study to Evaluate the Therapeutic Equivalence of Ketoconazole Cream 2% in the Treatment of Tinea PedisIsotretinoin In Preventing Recurrences In Chronic Recurrent Dermatophytosis
P1050
P1889
Feline dermatophytosis: aspects pertinent to disease management in single and multiple cat situationsAnimal model of dermatophytosisTinea genitalis: a new entity of sexually transmitted infection? Case series and review of the literatureDermatophytosis caused by Microsporum gypseum in infants: report of four cases and review of the literature.Anti dermatophytic therapy--prospects for the discovery of new drugs from natural products.Feline dermatophytosis: steps for investigation of a suspected shelter outbreak.
P921
Q61894256-569CFA30-1DEE-4AEE-8552-887169E8B0A7Q61914448-09FA9AC7-E270-41E6-8248-899D190D5596Q61936553-A41C6D52-0D1B-4564-8668-9C03CFEF5D6FQ61979453-81515DAC-FCE6-4E6E-9F93-E5CE26AAD30BQ61980733-833DA949-BAE9-4B81-BC6E-920B9DA3FA99Q62034518-A62F3FFC-CF6B-4745-A00C-141F1424EE58Q63319256-0CAFA930-6AD2-4997-B042-22F5B0474145Q63320626-52FAFCD9-DF95-4B80-8CAC-DD2222621E15Q63334986-8371EF04-805C-4966-882F-067517B804B9Q63336091-D3FC21E3-661A-493D-9DF6-021F9A8A2E99Q63337607-4942E78D-4A85-4325-99F8-44C3C588BC68Q63534917-D85EA316-72E8-4786-8A43-599664177089Q63580022-B4C21526-0353-4591-B1F4-9041769E0D71Q63596899-81E5513E-DC68-41B0-B4F4-AD6A668EF19FQ63807688-21D26F75-6FAD-4243-AE5C-AF13F2B929D7Q63814178-724D8768-C802-4EE5-8479-FBC29FED939EQ63814284-2564758B-1D09-48AD-B64C-AD5BFBE2D735Q63830480-C2B19C02-A2AD-45FA-98FF-9FDEE8A23A0CQ63833174-D2DBBC13-DEA7-43EC-8D63-167DDDF9D04BQ64184320-0146E829-065F-458A-98AD-0B0346BDF244Q64375361-BCDDA879-4ADD-48A3-9137-D74B38A9F48FQ64602597-676FA8B4-F089-4EDD-953D-7B80240BF10EQ64606771-EE412D41-04C3-4259-A757-67A758A3EC08Q64640111-574D3239-F0B2-4D4A-AF60-3493866B3789Q64644506-507C6D35-D006-47CE-9E32-451D2D5B4727Q64644508-9ED73371-33F4-4AC3-82A7-69FE3E9B9231Q64648144-CD974DC2-8A33-4BB4-8E63-8E5F6E8541E4Q64650641-1AB16B7A-294F-4484-BC5C-47F8D475D854Q64655879-B8C289E5-14E3-49D0-BC47-A7973FA1D1A0Q64677631-EBDE020D-D0D8-44DE-91EB-7B7F1A955424Q64680471-EB2334C4-C8B7-41D5-A8AD-ACB947D57C0DQ64694817-530B1F3D-6AB9-48A6-A77D-2989C102A3B4Q64708795-41A2F640-300A-4050-BB4D-D7DB7C8F431AQ64708914-6BEDAEA2-4C8F-4164-AAA1-85577B27E056Q64715730-9C11A53D-B459-4AE4-97B9-830FCA6C38CDQ64716186-5FC8E911-9D86-47BA-A578-E79A49648549Q64716800-CB5A8927-FD07-4DB0-A8C8-7CAE4C668D27Q64716802-039C0955-79E3-4F7C-AB73-FC71C05A975BQ64793581-EADB001C-79FE-4967-B911-1EC6B10528F6Q64803867-F04E8603-3472-41E5-9D07-081DB652257C
P1050
Q2392530-995650C5-0DBC-4C5F-AE9B-EDD86C434E96Q3359058-D4ED1610-1A09-4DD1-BC35-22F271CB6A51Q407883-5FD1A377-CA68-4C55-A652-F93DEBCC4B8EQ411229-9EDE3DA9-6501-4511-9D55-5B774AEB606CQ413586-2427A9CE-7280-48D9-87ED-FC644DBC9574Q415238-28AD3023-410C-4B24-A1B9-06DBA1E07DA9Q415259-1BF7E772-11B3-402F-BFEC-47DC998D2B50Q416096-9F8F394B-9616-4981-B4A9-D8F00B0F957BQ417141-D6893C60-F70B-462D-8FA1-5C6F01555FAEQ419468-55531FE4-AABE-457D-903B-BDE315200DB8Q5134338-3A1FBCE3-E978-43ED-BF91-216F99C78326Q5643439-5A26C73E-F61E-46C3-A226-F831AA7523F0Q75163056-90D59959-B202-48E7-9E39-C617BBE1EE0DQ850729-8B5CD05A-90B6-40C3-B24D-7B16FCE47EB2
P2175
description
Human disease
@en
Infeksi jamur pada kulit
@id
Krankheit
@de
groupe de mycoses
@fr
malattia
@it
مرض يصيب الإنسان
@ar
name
Tinea
@en
Tinea
@id
derwreinen
@cy
hudsvamp
@sv
teignes
@fr
tinea
@nn
سعفة
@ar
癬
@yue
癬
@zh
type
label
Tinea
@en
Tinea
@id
derwreinen
@cy
hudsvamp
@sv
teignes
@fr
tinea
@nn
سعفة
@ar
癬
@yue
癬
@zh
altLabel
Dermatophytosis-tinea/ringworm
@en
Microsporic tinea, NOS
@en
Tinea Infection
@en
Tinea
@en
ringworm
@en
tinea infection
@en
tinea
@en
prefLabel
Tinea
@en
Tinea
@id
derwreinen
@cy
hudsvamp
@sv
teignes
@fr
tinea
@nn
سعفة
@ar
癬
@yue
癬
@zh
P2176
P672
P486
P1748
P1889
P2176
P279
P2888
P2892
P31
P373
P3827
P486
P5270
MONDO:0005982
P672
C01.539.800.200.720
C01.703.295.872
C17.800.838.208.883
P699
DOID:12404